Foxo Technologies Inc - SIC # 7374 - COMPUTER PROCESSING AND DATA PREPARATION AND PROCESSING SERVICES

Ticker Exchange SIC # Website Latest Ticker
FOXO American 7374 http://delwinds.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Foxo Technologies Inc

FOXO Technologies Subsidiary, Myrtle Recovery Centers, Receives Two Full Licenses from the Tennessee Department of Mental Health and Substance Abuse Services - Aug 8th, 2024 12:30 pm
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements - Jul 16th, 2024 8:30 pm
Foxo Technologies, Inc., Regains Compliance with SEC Reporting Requirements - Jul 1st, 2024 12:30 pm
FOXO Technologies Inc. Secures Up to $2.8 Million in Senior Notes to Fund Previously Announced Acquisition of Myrtle Recovery Centers, Inc. and Provide Additional Working Capital - Jun 18th, 2024 12:30 pm
RENNOVA HEALTH, INC. ANNOUNCES STOCK EXCHANGE AGREEMENTS WITH FOXO TECHNOLOGIES, INC. FOR TWO OPERATING SUBSIDIARIES - Jun 17th, 2024 12:30 pm
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements; Completes Steps it Believes are Required to Regain Compliance - Jun 14th, 2024 9:30 pm
FOXO Technologies Enters into Share Exchange Agreements to Acquire Healthcare Operations from Rennova Health, Inc. - Jun 14th, 2024 12:30 pm
FOXO Technologies Announces Non-Binding Agreement for Potentially Transformative Merger with M2i Global - Feb 14th, 2024 2:32 pm
FOXO Technologies Announces Appointment of Capital Markets Veteran Francis Colt deWolf to the Board of Directors - Jan 25th, 2024 10:00 pm
FOXO Technologies Formalizes License Agreement with KR8.ai to Power New Epigenetic Wellness Solutions - Jan 22nd, 2024 1:30 pm
FOXO Technologies On Track to Commence Commercial Rollout of VITHAR™ AI Health Coach in Early 2024 - Dec 1st, 2023 2:01 pm
FOXO Technologies Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q - Nov 29th, 2023 9:30 pm
FOXO Technologies Provides Reminder for Webinar to be Held Today, November 10th at 10 AM Eastern Time, to Unveil VITHAR™ AI Health Coach - Nov 10th, 2023 1:30 pm
FOXO Technologies to Unveil VITHAR™ AI Health Coach; Schedules Webinar for Friday, November 10th at 10 AM Eastern Time - Nov 8th, 2023 2:00 pm
FOXO Technologies Expects Class A Common Stock to Resume Trading, Today, November 7, in Connection with 1-for-10 Reverse Stock Split - Nov 7th, 2023 2:23 pm
FOXO Technologies Unveils Plans for New Direct-to Consumer Offering Combining the Company’s Epigenetic Data with the Power of AI - Oct 30th, 2023 12:30 pm
FOXO Technologies Inc. Announces Reverse Stock Split - Oct 27th, 2023 9:15 pm
FOXO Technologies Completes Strategic Alternatives Review and Outlines Latest Progress Executing Corporate Strategy - Oct 23rd, 2023 12:00 pm
FOXO Technologies Announces Issue Notification from USPTO for a Patent Leveraging Machine Learning Approaches to Enable the Commercialization of Epigenetic Biomarkers - Oct 13th, 2023 12:00 pm
FOXO Technologies™ Interim CEO Mark White Provides Letter to Shareholders Outlining New AI-Enabled Direct-to-Consumer Strategy and Immediate Expense Reductions - Oct 6th, 2023 12:30 pm